TexasMarvL
3 weeks ago
I'm going to repeat myself.
BOTTOM LINE:
AXIM and MJNA insiders have control over ALL the AXIM assets. Verséa Ophthalmics is building their business on the foundation of the exclusive marketing agreement for three of the AXIM Dry Eye Disease Tear based Point-of-Care tests.
MY OPINION:
Personally I have been a "big" buyer below a penny in the last month or two. This is not investment advice. Penny stocks can have a high level of volatility. There is a risk of losing everything invested in AXIM. Don't invest money needed for food or rent or happiness.
STANDING ON A LIMB OPINIONS:
If my analytical brain studies the two paragraphs above I arrive at the following conclusion.
First, AXIM is out of cash and possibly getting closer to running out of insider credit. AXIM & MJNA still control 100% of the AXIM assets. Someone with deep pockets allows the party to continue. When will the credit cards be cut in half?
Second, we know Verséa Ophthalmics has an exclusive merchandising agreement with AXIM for three AXIM tests, 2 of which are FDA cleared.
In my opinion, it makes a lot of sense for Verséa Ophthalmics to have more control over their own future. That would imply shared ownership over the assets controlled by a financially struggling AXIM. Based on nothing but opinion, I believe some form of merger is in progress behind the scenes. Possibly a stock for stock (no cash) merger that allows all parties to retain ownership but also allows Verséa Health shared ownership over the AXIM portfolio of products. In this scenario everyone wins including retail investors. Verséa Health can IPO the consolidation and raise needed money for the combined business.
Maybe farfetched. 100% opinion.
My theory is based on an analytical exercise focused on the needs and assets of the two companies joined by the marketing agreement. On paper it could work out for everyone if a merger can agree on the value of each business.
Hope this limb doesn't break.
Not investment advice.
TexasMarvL
3 weeks ago
$53,000 in Q1 revenue. This is bare bones revenue and according to my original ballpark math, there was $45,000 in new start-up revenue and only about $8000 in re-order revenue.
This actually makes sense. It takes time to get staff trained on the new tests. It takes time to get staff focused on selling the new tests.
This is my original ballpark math
15×300×$10=$45,000 for initial start-ups in Q1.
One new location per week.
15 locations
300 initial tests ordered at startup.
AXIM gets $10 per test
Reorders per location per month may be between 50 and 150 tests. If we can estimate 100 tests per location per month it makes the math easier.
15×100×3×$10=$45,000.
15 locations
100 tests re-ordered each month.
3 months in a quarter.
AXIM gets $10 per test
TexasMarvL
1 month ago
No in my opinion it will take a few quarters.
This is my ballpark math
15×300×$10=$45,000 for initial start-ups in Q1.
One new location per week.
15 locations
300 initial tests ordered at startup.
AXIM gets $10 per test
Reorders per location per month may be between 50 and 150 tests. If we can estimate 100 tests per location per month it makes the math easier.
15×100×3×10=$45,000.
15 locations
300 initial tests ordered at startup.
3 months in a quarter.
AXIM gets $10 per test
Excluded from sales is the cost of the readers because AXIM makes no money on the readers.
If my math is correct,
AXIM sales in Q1 will be about $100,000.
My guess sales in Q2 should be about $250,000.
Someone smarter then me could probably use Algebra or Geometry to predict future revenue growth.
Good luck.
Not investment advice.
These opinions are my own best guess with almost no communication from AXIM Management.
TexasMarvL
1 month ago
Versea Health, Inc., a Stock Corporation, is a business entity located in Tampa, FL. Officially filed on April 4, 2024, this corporation is recognized under the document number 6173732. Governed by the California Secretary of State, the corporation maintains an active filing status. Last Updated 5/8/2024 8:12:42 PM
I have no idea what any of this means. Link to website:
https://www.bizprofile.net/fl/tampa/versea-health-inc
A stock corporation governed by the state of California. Officially filed April 4th. Statement of information filed on April 19th. Document Number 6173732 was last updated 5/8/2024 8:12:42 PM
TexasMarvL
1 month ago
The entry from California is dated April 4th, 2024 and the details from the website in previous post are the following:
BTW, I'm going to search on the filing number 6173732 to see what turns up. Do we have something happening behind the scenes that will soon be reported in a press release???
VERSEA HEALTH, INC. is a California Stock Corporation - Out Of State - Stock filed on April 4, 2024. The company's filing status is listed as Active and its File Number is 6173732.
The Registered Agent on file for this company is Corporation Service Company Which Will Do Business IN California As Csc - Lawyers Incorporating Serv and is located at 2710 Gateway Oaks Drive Ste 150n, Sacramento, CA 95833. The company's principal address is 603 East Cass Street, Tampa, FL 33602 and its mailing address is 603 East Cass Street, Tampa, FL 33602.
The company has 3 contacts on record. The contacts are Jillian Berswick from Tampa FL, Robert Glashow from Tampa FL, and Sean Fetcho from Tampa FL.
TexasMarvL
1 month ago
Hey Blue, Another question here. What is the California website that keeps track of corporations there in California? Any information you can provide is appreciated.
Thanks.
This Bizapedia website seems to say that Sean Fetcho is associated with corporations in Florida. New York and California.
https://www.bizapedia.com/people/sean-fetcho.html
"These individuals collectively are associated with 11 companies in Clearwater FL, New York NY, Sacramento CA, Tallahassee FL, and Tampa FL."
I'm just trying to dig and find out what might be unique about Verséa and how that might relate to California and New York.